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Brain function depends on coordinated interactions between neurons and glial cells. Recent
evidence indicates that these cells release endosome-derived microvesicles termed exo-
somes, which are 50–100 nm in size and carry speciﬁc protein and RNA cargo. Exosomes
can interact with neighboring cells raising the concept that exosomes may mediate signal-
ing between brain cells and facilitate the delivery of bioactive molecules. Oligodendrocytes
myelinate axons and furthermore maintain axonal integrity by an yet uncharacterized path-
way of trophic support. Here, we highlight the role of exosomes in nervous system cell
communication with particular focus on exosomes released by oligodendrocytes and their
potential implications in axon–glia interaction and myelin disease, such as multiple sclero-
sis. These secreted vesicles may contribute to eliminate overproduced myelin membrane
or to transfer antigens facilitating immune surveillance of the brain. Furthermore, there is
emerging evidence that exosomes participate in axon–glia communication.
Keywords: microvesicles, exosomes, neuron–glia communication, oligodendrocytes, axon–glia interaction, myelin
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INTRODUCTION
Glial cells actively participate in brain development and function
necessitating communication betweenneurons and glia (Allen and
Barres, 2009). Their functions range from metabolic support to
myelination, immune defense, and engagement in synapse for-
mation and plasticity. Oligodendrocytes ensheath axons with an
insulating myelin sheath facilitating electric impulse propagation.
Myelination requires intense communication between oligoden-
drocytes and neurons, which is also essential for the maintenance
of axonal integrity over the lifetime (Nave, 2010a).
Recent reports describe the horizontal transfer of biomolecules
by secreted extracellular vesicles, which is increasingly becom-
ing established as a general mode of intercellular communication
(Simons and Raposo, 2009; Camussi et al., 2010). Neurons and
the major types of glia release vesicles, raising the possibility
that communication mediated via extracellular vesicles is a com-
mon mechanism in the CNS. Small vesicles, here referred to
as microvesicles, shed directly from the plasma membrane or
originate from the endosomal system (Lakkaraju and Rodriguez-
Boulan, 2008; Cocucci et al., 2009). A mixed population of such
vesicles has been detected in body ﬂuids including cerebrospinal
ﬂuid (Vella et al., 2008). Exosomes are released by fusion of
multivesicular bodies (MVBs) with the plasma membrane and
secretion of the intraluminal vesicles (ILVs) into the extracel-
lular space. They are 50–100 nm in diameter and carry speciﬁc
protein and RNA cargo. Exosomal membranes are enriched in
cholesterol and sphingomyelin. Proteins relating to their biogen-
esis (Alix and Tsg101), distinct cytosolic proteins such as heat-
shock proteins, and certain membrane proteins (tetraspanins,
integrins) are sorted into exosomes whereas others are excluded
(for review, see Thery et al., 2009; Thery, 2011, and references
therein).
Cells utilize exosomes to dispose of unwanted proteins or
to exchange signals with neighboring cells. As an example, ery-
throcytes remove the transferrin receptor via exosomes during
maturation, instead of eliminating it via internal degradation.
Proteins implicated in cell interaction are strikingly abundant in
exosomes, which thus suggests a role in cell–cell communication.
In the immune system,antigen presenting cells (APCs) release exo-
somes containing MHC and costimulatory molecules to modulate
T-cell activation (Thery et al., 2009). Furthermore, microvesicles
(including exosomes) transport miRNAs and mRNAs from cell to
cell. Translation of microvesicle-derived mRNAs is initiated and
new proteins are synthesized. In turn, transferred miRNAs inhibit
expression of resident proteins. Thus, shuttled RNAs can alter the
proteome of recipient cells (Valadi et al., 2007; Skog et al., 2008;
Pegtel et al., 2010; Zhang et al., 2010).
This review describes the characteristics and functions of
microvesicles secreted by neurons and glia (collectively referred
to as neural cells), with particular focus on exosomes released
by oligodendrocytes. We propose a role of oligodendroglial exo-
somes in axon–glia interaction and hypothesize that they shut-
tle functional molecules to neurons, thus inﬂuencing neuronal
properties.
CLASSIFICATION AND GENERAL COMPONENTS OF
EXOSOMES
Exosomes and other microvesicles can be isolated from culture
supernatants or body ﬂuids by differential centrifugation and ﬁl-
tration. With current technology, the isolation of extracellular
vesicles directly from tissues is impossible because membrane
debris and internal vesicles contaminate the preparation. Fur-
thermore, discrimination between different types of microvesicles
is difﬁcult. To distinguish exosomes from other secreted vesicles,
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their characteristic size (diameter below 100 nm), protein compo-
sition, density, and endosomal origin are commonly used criteria.
Exosomes are derived from MVBs and correspond to the ILVs,
which bud from the limiting membrane into the lumen of late
endosomes. ILV-budding involves the action of the ESCRT (endo-
somal sorting complex required for transport) machinery, though
its exact role in exosome biogenesis is not clear and appears cell-
type dependent (Simons and Raposo, 2009; Bobrie et al., 2011).
Anyhow, ESCRT and associated proteins such as Tsg101 and Alix
are integrated in exosomes and serve as markers of their identity.
In addition, ESCRT independent mechanisms of ILV formation
have been described involving sorting of exosome cargo to endo-
somal domains and ceramide-mediated budding from the limiting
membrane (Trajkovic et al., 2008; Buschow et al., 2009). Possibly,
distinct endosomal sorting mechanisms lead to the generation of
subpopulations of exosomes. MVB trafﬁcking and fusion is reg-
ulated by Rab-family GTPases. In oligodendroglial cells, Rab35
regulates docking of MVBs to the plasma membrane (Hsu et al.,
2010). Moreover, Rab27a and Rab27b are involved in the docking
step in Hela cells (Ostrowski et al., 2010).
Proteomic and microarray analysis on a range of exosome
preparations yielded a reproducible compendium of exosome-
associated proteins and RNAs, summarized in the database Exo-
carta (Mathivanan et al., 2012). Exosomes contain a distinct
set of proteins conserved across different cell types and species.
Typical proteins are cytoskeletal proteins such as tubulin and
actin, heat-shock proteins (Hsp70, Hsp90), metabolic enzymes of
the glucose metabolism, Flotillin-1, signal transduction proteins
(kinases, heterotrimeric G proteins), MHC molecules, clathrin,
proteins involved in transport and fusion (annexins, Rab pro-
teins), and translation elongation factors. Strikingly abundant
in exosomes are proteins of the tetraspanin family, e.g., CD9,
CD63, CD81, and CD82 (van Niel et al., 2006; Simpson et al.,
2008; Thery et al., 2009). Additionally, exosomes contain cell-
type speciﬁc components reﬂecting the host cell identity and
presumably also hinting at the biological function of the released
exosomes.
CHARACTERISTICS OF CNS EXOSOMES
In the CNS, neurons, microglia, astrocytes, and oligodendrocytes
have been reported to secrete microvesicles into the extracellu-
lar environment. In response to glutamatergic synaptic activity,
cultured cortical and hippocampal neurons release microvesicles
with the characteristics of exosomes. Neuronal exosomes carry
the cell adhesion molecule L1, the GPI-anchored prion protein,
as well as the GluR2/3 subunits of the AMPA receptor (Faure
et al., 2006; Lachenal et al., 2011). The Parkinson disease related
protein α-synuclein is secreted from a neuroblastoma cell line
by exosomes and can inﬂuence the viability of neighboring cells
(Emmanouilidou et al., 2010).
Oligodendrocytes release exosomes that include the lipids
galactocerebroside, sulfatide, and cholesterol (Krämer-Albers
et al., 2007), which are also prominent in oligodendroglial
lipid rafts and represent characteristic myelin lipids (Krämer
et al., 1997). The proteomic proﬁle of oligodendroglial exo-
somes mirrors the exosome-pattern of marker proteins (Alix,
Tsg101, Flotillin-1), ubiquitous tetraspanins (CD81, CD63), and
chaperones (Figure 1). They are furthermore characterized by
the presence of unique myelin proteins, such as PLP, CNP,
MAG, and MOG. Remarkably, oligodendroglial exosomes carry
a range of enzymes such as the NAD-dependent deacety-
lase sirtuin-2, oxidative stress alleviating peroxiredoxins and
FIGURE 1 | Characteristics of oligodendroglial exosomes. (A) Electron
micrograph of exosomes in the extracellular space released by primary
oligodendrocytes. Immuno-gold labeling was performed with antibodies
recognizing myelin-associated glycoprotein (MAG). Asterisk indicates the
putative MVB fusion proﬁle that resulted in exosome release. Scale bar,
100 nm. (B) Protein composition of a typical oligodendroglial exosome. The
illustration is based on proteomic analyses of exosome preparations derived
from oligodendroglial cells (Krämer-Albers et al., 2007).
Frontiers in Physiology | Membrane Physiology and Biophysics April 2012 | Volume 3 | Article 119 | 2
Frühbeis et al. Exosomes in nervous system cell communication
dihydropyrimidinase-related proteins, and glycolytic enzymes
(GAPDH, pyruvate kinase, α-enolase).
Microglia are the resident macrophages of the CNS. In patho-
logical situations, they become activated and execute immune
functions such as antigen presentation (Kettenmann et al., 2011).
Microglia secrete exosomes containing the expected exosomal
proteins as well as a set of proteins previously reported for B
cell- and dendritic cell-derived exosomes. In addition, they carry
the surface-bound aminopeptidase N (CD13) and the monocar-
boxylate transporter 1 (MCT1). CD13 cleaves N-terminal amino
acids from polypeptides and exosome-associated CD13 degrades
enkephalins, inﬂuencing the activity of ligands of the opioid recep-
tor and thus neuronal cAMP levels. Since these exosomes contain
the lactate transporter MCT1 together with glycolytic enzymes,
they may serve to deliver energy substrates to neurons (Potolicchio
et al., 2005). Moreover, microvesicles carrying the proinﬂamma-
tory cytokine IL-1β shed from the plasma membrane of microglial
cells and astrocytes in response to ATP stimulation and activation
of acid sphingomyelinase (Bianco et al., 2009).
In response to oxidative and heat stress, cultured astro-
cytes release elevated amounts of the heat-shock protein 70
(Hsp/Hsc70) as well as synapsin 1 in association with exosomes
(Taylor et al., 2007; Wang et al., 2011). Intriguingly, astrocyte-
derived exosomes have been reported to contain mitochondrial
DNA (Guescini et al., 2010). Secretion of microvesicles comprising
a mixture of exosomes, shedding vesicles, and possibly also apop-
totic bodies is a prominent feature of brain tumor cells,whichoften
originate from astrocytes (van der Vos et al., 2011). Microvesicles
derived from highly aggressive glioblastoma multiforme tumors
(GBM), carry oncogenic EFGRvIII in addition to immunosup-
pressive and angiogenic factors (Al-Nedawi et al., 2008; Graner
et al., 2009). They are moreover characterized by the presence
of nucleic acids, including mRNAs, miRNAs, non-coding RNAs,
retrotransposon elements, genomicDNA, and cDNAderived from
oncogenic sequences (Skog et al., 2008; Balaj et al., 2011).
FUNCTIONS OF NERVOUS SYSTEM EXOSOMES
Two general functions have been ascribed to exosome secretion:
disposal of unneeded cell components and signaling to neighbor-
ing cells involving the horizontal transfer of biomolecules (Lotvall
and Valadi, 2007; Simons and Raposo, 2009). Both functional
properties assigned to exosomes appear eligible to be utilized by
neural cells, which operate as a long-term cellular network rely-
ing on ﬁnely tuned cell–cell interactions, mutual support, and the
clearance of remnants. The physiological and pathological impact
of exosomes in the nervous system has been a topic of discussion
(Smalheiser, 2007; Aguzzi and Rajendran, 2009), however, we are
only beginning to capture a true picture (Figure 2). Exosomes
secreted by neurons have been implicated in synaptic plasticity.
Enhanced glutamatergic activity within cultures of mature corti-
cal neurons stimulates the release of exosomes carrying the AMPA
receptor subunit GluR2 from the somatodendritic postsynaptic
compartment (Lachenal et al., 2011). These ﬁndings suggest that
activity-dependent exosome secretion may help to adapt the efﬁ-
cacy of synaptic transmission by depletion of neurotransmitter
receptors from the postsynaptic compartment. What happens to
the exosomes after the release, whether they become internalized
by the presynaptic neuron or surrounding glial cells remains to be
determined.A synaptic transfer of wnt-signalingmolecules involv-
ing exosome-like vesicles has been shown to occur in drosophila
larva at the neuromuscular junction (Koles et al., 2012).
In the context of CNSpathology, it appears that pathogenic pro-
teins such as β-amyloid peptide, prion protein, α-synuclein, tau,
and superoxide dismutase are released from cells in association
with exosomes (Fevrier et al., 2004; Rajendran et al., 2006; Gomes
et al., 2007; Emmanouilidou et al., 2010; Saman et al., 2011).
These proteins have in common the activity to form aggregates
(amyloids, prionoids) that escape the normal cellular degrada-
tion machinery. It is not clear yet whether exosome-associated
secretion of amyloidogenic proteins helps to relieve cells of poten-
tially detrimental components, or if the pathogen-ﬁlled exosomes
engage in propagating neurodegenerative “seeds” within the tis-
sue. Exosomes carrying prions have been shown to be infectious
(Fevrier et al., 2004; Vella et al., 2007). However, the process-
ing of pathogenic exosomes by recipient cells remains to be
demonstrated.
More is known about the role of membrane vesicles released
by glial cells. Microvesicles (including exosomes) are released by
glioma cells, which carry the mRNA and protein of oncogenic
EGFRvIII as well as angiogenic factors. They can be internalized
by surrounding cells, promoting cell transformation or mediat-
ing tubular growth of endothelial cells (Al-Nedawi et al., 2008;
Skog et al., 2008; Graner et al., 2009; Svensson et al., 2011; van
der Vos et al., 2011). Thus, glioma-derived microvesicles appear to
modulate the environment to favor tumor growth. Intriguingly,
tumor-derived microvesicles can also be detected in the circu-
lation of glioma-bearing mice or human glioblastoma patients
demonstrating that they are produced in vivo and are capable of
crossing the bloodbrain barrier.Microvesicle release fromprimary
cortical astrocytes and microglial cells appears to be triggered by
ATP-mediated activation of P2X7 receptors and downstream stim-
ulation of acid sphingomyelinase (Bianco et al., 2009). A recent
study suggests that this special type of microvesicle signals to neu-
rons resulting in modulation of synaptic activity (Antonucci et al.,
2012). Application of microvesicles isolated from ATP-stimulated
microglial cells to neurons in vitro and in vivo gave rise to increased
neurotransmission, that appeared to be due to an enhanced release
probability at the presynaptic site. However, the contribution of
exosome release to these phenomena is unclear. Scanning electron
micrograph pictures of glioma cells and ﬂuorescence microscopy
analysis of ATP-stimulated glial cells, as well as the heterogeneous
size proﬁle of the released microvesicles indicate that shedding
from the cell surface is the dominant form of vesicle generation in
these paradigms.Nevertheless, it is possible that exosomes account
for some of the described functions since they are also present in
the vesicular fractions analyzed. Astrocytes release exosomes car-
rying Hsp70 and synapsin 1 in response to heat or oxidative stress,
which have been suggested to ship neuroprotective cargo to neu-
rons facilitating their survival (Taylor et al., 2007). Intriguingly,
synapsin 1 is ﬁrst released from the exosomal cytosolic compart-
ment under these conditions, before it acts on neurons in its
soluble form (Wang et al., 2011).
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FIGURE 2 | Postulated roles of microvesicles in neural cell
communication. Neural cells release different types of microvesicles with
several known or suggested functions. Neurons secrete exosomes which
may inﬂuence synaptic plasticity. Microglia modulate neurotransmission via
shedding microvesicles. Astrocyte-derived exosomes carry neuroprotective
cargo and could contribute to neuronal survival. Neuronal signals trigger
exosome release from oligodendrocytes by raising intracellular Ca2+-levels.
Upon internalization by neurons these exosomes could provide support to
axons. Microglia take up and degrade oligodendroglial exosomes without
changing their inﬂammatory properties. Under speciﬁc pathological conditions
these exosomes may transfer antigens to microglial cells or other APCs and
induce inﬂammatory responses.
ROLE OF OLIGODENDROGLIAL EXOSOMES IN CELL
COMMUNICATION
Oligodendrocytes secrete MVB-derived exosomes in a Ca2+-
dependent fashion, which also carry mRNA and miRNA in addi-
tion to myelin proteins and lipids (Krämer-Albers et al., 2007;
Krämer-Albers et al., unpublished observations). These exosomes
appear to convey autocrine signals that inhibit membrane expan-
sion and myelin formation by oligodendrocytes in culture in
response to neuron-derived trophic factors (Bakhti et al., 2011).
This autocrine signaling pathway does not involve exosome rein-
ternalization but is mediated by activation of second messenger
cascades involving RhoA, Fyn, and FAK. Furthermore, it has
been shown that microglia take up oligodendroglial exosomes
by macropinocytosis, which subsequently become degraded and
apparently fail to provoke an immune response (Fitzner et al.,
2011). Internalization is observed preferentially in MHC class II
negative microglia and does not promote microglial activation.
The authors suggest that microglia are engaged in the degradation
of excess myelin components secreted by the exosome pathway. It
will be interesting to determine whether exosomes derived from
oligodendrocytes exposed to pathogens or speciﬁc forms of stress
will be able to induce an inﬂammatory response. This is particu-
larly relevant to the still unresolved etiology of multiple sclerosis
and the question of how CNS self-antigens are transferred to
trigger a myelin-speciﬁc autoimmune response.
Our recent work indicates that oligodendroglial exosomes play
an important role in mutual communication between oligoden-
drocytes and neurons. We found that neurotransmitter release
stimulates oligodendroglial exosome secretion by activating Ca2+-
permeable ionotropic receptors on the surface of oligodendro-
cytes. Furthermore, neurons internalize oligodendroglial exo-
somes by endocytosis and utilize their cargo (submitted manu-
script). These ﬁndings suggest that neuronal activity triggers the
transfer of oligodendroglial exosomes and their cargo to neurons.
Thus, neurons would regulate their supply of glia-derived exo-
somal proteins, mRNAs, and miRNAs. Myelinated axons exist as
long protrusions at a distance from the neuronal cell body and are
shielded from the CNS environment by the myelin membrane
(Nave, 2010b). Hence, external support by exosome-mediated
transfer of glial substrates could be contributing to and be crit-
ical for long-term axonal maintenance. A lack of glial support
is modeled by PLP and CNP knockout mice, which develop a
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progressive axonal degeneration (Edgar and Nave, 2009). PLP
and CNP are both components of oligodendroglial exosomes
and thus, it is tempting to speculate about the potential contri-
bution of exosomes to glial support. Oligodendroglial exosomes
additionally include substances that can contribute to neuropro-
tection such as Hsp/Hsc70. There is evidence that the squid giant
axon locally picks up Hsps from periaxonal glial cells (Tytell
et al., 1986) and it was indeed suggested that the transfer is
mediated by exosomes (Tytell, 2005). Moreover, newly synthe-
sized glial RNAs are delivered to the giant axon in response
to axonal depolarization (Eyman et al., 2007). In the PNS, it
has been described that axons receive ribosomal subunits in
association with vesicles from myelinating Schwann cells (Court
et al., 2008). It will be interesting to determine, whether oligo-
dendroglial exosomes exhibit neuroprotective or neurotrophic
functions.
RELEVANCE FOR MYELIN DISEASE
Myelin diseases are characterized by a developmental hypo/
dysmyelination or a secondary demyelination. They can be inher-
ited (leukodystrophies) or acquired such as multiple sclerosis.
The pathology of multiple sclerosis involves an immune-mediated
degeneration of the myelin sheath. Which factors direct the speci-
ﬁcity of the immune response toward myelin and whether myelin
antigens in multiple sclerosis are processed by APCs is unknown.
Exosomes are known to deliver antigens to APCs (Bobrie et al.,
2011). In spite of reports that oligodendroglial exosomes appear
not to activate microglia, it is feasible that other APCs such as
dendritic cells, which invade the CNS under certain conditions,
process oligodendroglial exosomes and present the antigens on
their surface to initiate an immune response. Future studies will
determinewhether oligodendroglial exosomes canmediatemyelin
antigen transfer to dendritic cells. Furthermore, exosome compo-
sition may be altered in certain pathological conditions, causing
a switch of immunologically inert into immunologically active
exosomes. Oligodendroglial exosome composition indeed may be
altered in Pelizaeus–Merzbacher disease (PMD) resulting from
duplications in the PLP1 gene. Overexpression of PLP leads to
its accumulation in late endosomes (Simons et al., 2002) and may
yield an increased release of PLP in association with exosomes.
Increased exosome release or an altered exosome protein/lipid
stoichiometrymay thus trigger inﬂammatory reactions in theCNS
contributing to PMD pathology.
Common to most myelin diseases is the phenomenon of pro-
gressive axonal degeneration due to lack of glial support. This
secondary neuronal damage is the major cause of irreversible
disability and death of the patients. Thus, it is of clinical impor-
tance to decipher the potential implications of oligodendroglial
exosomes in neuroprotection and to identify the beneﬁcial com-
ponents, with the ultimate goal to develop therapeutic strategies
mitigating axonal degeneration. Furthermore, there is accumu-
lating evidence that exosomes qualify as promising vehicles for
the delivery of therapeutic agents into the brain, as they can be
delivered across biological barriers such as the blood brain barrier
(Lakhal and Wood, 2011).
CONCLUSION
The hypothesized role of secreted microvesicles/exosomes in
neural cell communication is materializing into a picture sub-
stantiated by experimental evidence (Figure 2). Microvesicles may
execute their functions by distinct modes of action: (1) internal-
ization by target cells and cargo retrieval, (2) binding to the cell
surface and triggering second messenger pathways, and (3) release
of components into the extracellular matrix. However, their inter-
action with target cells is not well understood at a mechanistic
level. To date,most theories of exosome function have arisen from
in vitro data. The ﬁeld awaits genetic mouse models that interfere
withneural exosome secretion todemonstrate the in vivo relevance
of exosome-mediated processes. Nonetheless, the versatile role of
CNS microvesicles opens up new perspectives for the understand-
ing and treatment of neurodegenerative diseases includingdiseases
of myelin.
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